Back to top
more

Henry Schein (HSIC)

(Delayed Data from NSDQ)

$70.37 USD

70.37
1,742,354

+0.14 (0.20%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $70.37 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (101 out of 250)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Here's Why You Should Invest in Henry Schein (HSIC) Stock

Henry Schein's (HSIC) strategy to extend digital dentistry globally is encouraging. Recent acquisitions will strengthen its foothold in the high-potential dental market.

    HSIC or MMSI: Which Is the Better Value Stock Right Now?

    HSIC vs. MMSI: Which Stock Is the Better Value Option?

      Henry Schein's 3 Investments to Fortify Dental Implant Arm

      Intra-Lock, Medentis Medical and Pro-Cam Implants jointly are likely to prove conducive to growth for Henry Schein's (HSIC) existing implant-based tooth replacement solutions line.

        Henry Schein (HSIC) Down 2.4% Since Last Earnings Report: Can It Rebound?

        Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

          Medical - Dental Supplies Outlook: Long-Term Prospects Bright

          The ongoing digital transition is posing challenges to dental industry players in the wake of growing oral hygiene awareness and increasing incidence of dental diseases.

            Henry Schein's (HSIC) Q2 Earnings Beat, '18 EPS View Up

            All four of Henry Schein's (HSIC) operating segments recorded strong year-over-year growth in Q2.

              Henry Schein (HSIC) Beats Q2 Earnings and Revenue Estimates

              Henry Schein (HSIC) delivered earnings and revenue surprises of 1.96% and 0.73%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

                Medical Product Stock Earnings on Aug 6: CAH, HSIC & More

                The Medical product market gains momentum owing to the recent two-year suspension of the controversial 2.3% Medical Device tax.

                  Can Dental Growth Drive Henry Schein's (HSIC) Q2 Earnings?

                  Henry Schein (HSIC) is strongly placed to gain from the ongoing trend of digitalization in the global dental market.

                    HSIC vs. ALGN: Which Stock Is the Better Value Option?

                    HSIC vs. ALGN: Which Stock Is the Better Value Option?

                      What's in Store for GNC Holdings (GNC) This Earnings Season?

                      GNC Holdings' (GNC) revenues are likely to decline on a year-over-year basis, owing to weakness in U.S. & Canada segments in Q2.

                        Will Edwards' (EW) Steady Overall Growth Drive Q2 Earnings?

                        Edwards Lifesciences (EW) expected to gain from strength in all business segments and geographies in Q2.

                          Can Overall Growth Drive Align Technology (ALGN) Q2 Earnings?

                          Align Technology (ALGN) likely to gain from strength in Invisalign space as well as Scanner and Service business in Q2.

                            Boston Scientific (BSX) Q2 Earnings: Is a Beat in Store?

                            Boston Scientific (BSX) expects to consistently gain from impressive growth across all business lines and geographies.

                              HSIC or MMSI: Which Is the Better Value Stock Right Now?

                              HSIC vs. MMSI: Which Stock Is the Better Value Option?

                                BD Buys TVA Medical, To Provide Minimally Invasive Procedure

                                The acquisition of TVA Medical will enable Becton, Dickinson (BDX) to treat patients with chronic kidney disease through minimally invasive procedures.

                                  Henry Schein's JV With Internet Brands to Boost Dental Arm

                                  Henry Schein (HSIC) and Internet Brands' newly formed JV is likely to deliver integrated dental technology for improving practice management, marketing as well as patient communication.

                                    Will Walgreens (WBA) Q3 Earnings Gain From Overall Strength?

                                    Walgreens Boots' (WBA) sales rise at the Retail Pharmacy USA segment on account of tie-ups along with strength in other businesses buoys optimism.

                                      MedTech Overcomes Policy Hurdles, Long-Term Prospects Bright

                                      With the suspension of the controversial 2.3% medical device tax for another two years, the medical device industry is currently riding high on optimism.

                                        Why is Henry Schein (HSIC) Down 1.1% Since its Last Earnings Report?

                                        Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                          Henry Schein's (HSIC) Q1 Earnings Beat, '18 View Intact

                                          We currently await the completion of Henry Schein's (HSIC) planned spin-off of global Animal Health business. This business contributes nearly 30% to the company's top line.

                                            Henry Schein's (HSIC) Q1 Earnings & Revenues Top Estimates

                                            Henry Schein's (HSIC) four global segments gained market share during Q1 and delivered solid earnings growth on back of the strategy to grow the business organically and through acquisitions.

                                              Can Overall Growth Drive Henry Schein's (HSIC) Q1 Earnings?

                                              Henry Schein (HSIC) likely to gain on strength across all business segments in Q1.

                                                Company News for Apr 24, 2018

                                                Companies in the news are: ALK,ASB,HSIC,HUM

                                                  Factors Setting Stage for CVS Health's (CVS) Q1 Earnings

                                                  CVS Health (CVS) expects robust 2018 PBM selling season and strong Pharmacy Services segment to drive earnings in Q1.